Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05622344 · ClinicalTrials.gov registry record · NA
StableEyes With Active Neurofeedback
A NA study of Vestibular Schwannoma and Vestibular Disorder, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 2
- Study locations
NCT05622344: Recruiting NA study of Vestibular Schwannoma and Vestibular Disorder, sponsored by Johns Hopkins University.
NCT05622344 is a NA study of Vestibular Schwannoma and Vestibular Disorder that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 48 participants, roughly in line with the 46-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05622344, a NA study of Vestibular Schwannoma and Vestibular Disorder, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.
Primary Outcome
Subjective rating of motion sickness intensity from 0 to 10. Zero denotes absent motion sickness while 10 denote vomiting.
Conditions Studied
Interventions
- BEHAVIORAL Traditional Therapy
- DEVICE SWAN
Study Locations (2)
Maryland
- Johns Hopkins University - Baltimore
Ohio
- Naval Medical Research Unit - Dayton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-08-08 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT05622344 shows while recruiting
NCT05622344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, roughly in line with the 46-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target.
The record links to 4 conditions, with Vestibular Schwannoma appearing as the primary indexed condition, and to 2 interventions - of which Traditional Therapy is the first listed.
NCT05622344 reports a single indexed study location in Maryland, Ohio.
Frequently Asked Questions
What is clinical trial NCT05622344 about?
NCT05622344 is a clinical study titled "StableEyes With Active Neurofeedback". The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.
What is the current status of trial NCT05622344?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2022-08-08. Estimated completion is 2026-09-30.
What conditions does trial NCT05622344 study?
This clinical trial studies the following conditions: Vestibular Schwannoma, Vestibular Disorder, Motion Sickness, Space Motion Sickness.
What interventions are being tested in trial NCT05622344?
The interventions under investigation include: Traditional Therapy (BEHAVIORAL), SWAN (DEVICE).
Who is sponsoring clinical trial NCT05622344?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05622344 being conducted?
This trial has 2 study locations across Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vestibular Schwannoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CI Following VS Removal or Labyrinthectomy
RECRUITING · NA
-
Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas
RECRUITING · NA
-
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
RECRUITING · Phase 1
-
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
-
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
ACTIVE NOT RECRUITING · Phase 2
-
Study of Aspirin in Patients With Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI